AXSM vs BHVN Stock Comparison
Compare AXSM vs BHVN on performance, valuation, growth, fundamentals, momentum and risk; the current AIQ evidence does not show a clear headline leader.
What is the main difference between AXSM and BHVN?
AXSM and BHVN are close on the current AIQ evidence, so the better fit depends more on objective, risk tolerance and valuation preference than on a single headline score.
AlgovestIQ AIQ Comparison
Axsome Therapeutics, Inc. vs Biohaven Ltd.
AXSM and BHVN are effectively level
AXSM and BHVN are effectively level on the AIQ Score; the factor table below shows where each one holds its advantage.
Axsome Therapeutics, Inc.
Biohaven Ltd.
The Algovestiq AIQ Score does not currently separate AXSM and BHVN as of Nov 15, 2026. Both names are scored on the same 0–100 scale across Quality, Value, Momentum and Risk Resilience, and the factor table below shows where each one holds its advantage.
Compare Axsome Therapeutics, Inc. and Biohaven Ltd. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare AXSM and BHVN against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum24 vs 78BHVN +54
- Quality57 vs 16AXSM +41
- Risk Resilience57 vs 35AXSM +22
Neither name separates cleanly on the covered dimensions.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Quality +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 4 active signals are unchanged.
Largest factor move: Momentum +1
New signals
- ADX Trend Weakening — neutral, trend, medium horizon
AXSM's lead narrowed by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — AXSM and BHVN both carry a full feed there.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
EvenNeither separates on the overall score.
Growth
AXSMAXSM on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
BHVNBHVN on the Momentum factor, by 54 points.
Lower downside
AXSMAXSM on Risk Resilience, by 22 points.
Analyst upside
BHVNBHVN on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AXSM | BHVN | Note |
|---|---|---|---|
| Implied upside to target | +83.6% | +113.5% | BHVN has more room |
| Target dispersion | +21.9% | +98.3% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 22 | 17 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
How each independent group of evidence reads the pair.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 47 vs 47 |
| Fundamentals | Even | EPS growth 74.7% vs 5.5%; TTM ROE -12.2% vs 131.6% |
| Valuation | Not covered | Not covered |
| Technicals | BHVN | Price vs 50-day -17.4% vs 2.2%; vs 200-day -28.1% vs 12.1% |
| Risk Resilience | AXSM | Risk Resilience 57 vs 35 |
| Analyst expectations | BHVN | Target upside 83.6% vs 113.5% |
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 0 points. (argues the conclusion is provisional)
- Only 0 of 5 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The lead has swung materially session to session. (argues the conclusion is provisional)
- Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)
How the comparison changed
120 daily snapshots · May 27 – Nov 13AXSM lead: Weakening — the AIQ differential moved from 15 to 0 points over 30 sessions.
- Today
- Level
- 47 vs 47
- 7 sessions ago
- BHVN +1
- 47 vs 48
- 30 sessions ago
- AXSM +15
- 51 vs 36
- 90 sessions ago
- AXSM +16
- 61 vs 45
The lead changed hands 2 times in this window, most recently on Nov 12 when AXSM moved ahead of BHVN.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 2 bearish / 1 neutral, conflicted
Only AXSM
- Death Cross Active — bearish, trend, long horizon (14.93%)
- Downtrend Structure Active — bearish, trend, long horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
3 bullish / 3 bearish / 2 neutral, conflicted
Only BHVN
- Golden Cross Active — bullish, trend, long horizon (9.68%)
- ADX Trend Weakening — neutral, trend, medium horizon
- Beta Spike Warning — bearish, risk_regime, long horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.33x)
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.86%, AIQ 0 points).
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -1.78%, AIQ +1 points).
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | AXSM | BHVN |
|---|---|---|
| Revenue growth (YoY) | 18.9% | 0% |
| EPS growth (YoY) | 74.7% | 5.5% |
| Gross margin | 93.2% | 0% |
| Operating margin | -17.7% | 0% |
| Return on equity (TTM) | -12.2% | 131.6% |
| Debt to equity | 2.07 | -3.06 |
Performance
BHVN leads 5 of 6 windows| Metric | AXSM | BHVN |
|---|---|---|
| 1 week (5 sessions) | 7% | -4.6% |
| 1 month (20 sessions) | -9.8% | 28.2% |
| 3 months (63 sessions) | -34.5% | -4.4% |
| 6 months (126 sessions) | -37.8% | 57.8% |
| Year to date | -22.4% | 22.4% |
| 1 year (252 sessions) | 0.6% | 73.8% |
Technicals
BHVN has the stronger structure| Metric | AXSM | BHVN |
|---|---|---|
| RSI (14) | 40.8 | 47.8 |
| ADX (14) | 37.2 | 24.5 |
| Price vs 50-day | -17.4% | 2.2% |
| Price vs 200-day | -28.1% | 12.1% |
| Volatility (1M, annualized) | 53.2% | 114.5% |
Risk
AXSM is the more resilient| Metric | AXSM | BHVN |
|---|---|---|
| Beta | 0.66 | 1.28 |
| Sharpe ratio | 0.2 | 1 |
| Sortino ratio | 0.34 | 1.74 |
| Max drawdown | -49.1% | -41.2% |
| Current drawdown | -44.5% | -18.5% |
| Annualized volatility | 45.8% | 83% |
| Value at risk (95%) | -4.1% | -6.7% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which has more analyst upside, AXSM or BHVN?
Analyst price targets imply +83.6% upside for AXSM and +113.5% for BHVN, so the Street currently favors BHVN. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AXSM or BHVN?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AXSM or BHVN?
AXSM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AXSM or BHVN?
BHVN on the Momentum factor, by 54 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AXSM or BHVN?
AXSM is the more resilient of the two, so the other name carries the higher downside risk. AXSM on Risk Resilience, by 22 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AXSM more profitable than BHVN?
BHVN leads on the comparable margin measures — gross margin 93.2% vs 0%; operating margin -17.7% vs 0%; ttm roe -12.2% vs 131.6%.
What do the current signals say about AXSM and BHVN?
AXSM: 1 bullish / 2 bearish / 1 neutral, conflicted. BHVN: 3 bullish / 3 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AXSM is Death Cross Active (bearish, long horizon). On BHVN it is Golden Cross Active (bullish, long horizon).
Compare AXSM and BHVN with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.